Management of Day 2 Fever with Positive Dengue NS1 Antigen

Diagnostic Confirmation and Risk Stratification

A positive NS1 antigen on day 2 of fever confirms acute dengue infection and requires immediate clinical assessment for warning signs, according to the Centers for Disease Control and Prevention, supportive care with close monitoring for progression to severe dengue, and patient education about danger signs—hospitalization decisions should be based on clinical warning signs rather than NS1 positivity alone 1, 2
NS1 positivity on day 2 confirms active dengue infection, as NS1 antigen is detectable as early as day 1 of symptom onset and remains positive during the first week of illness, as recommended by the World Health Organization 1, 3

Assess for WHO warning signs that indicate potential progression to severe dengue, including abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy or restlessness, and liver enlargement, as suggested by the Centers for Disease Control and Prevention 2, 4
The World Health Organization recommends supportive care, including adequate oral hydration and acetaminophen for fever, and daily monitoring for patients without warning signs 2, 4
The Centers for Disease Control and Prevention suggest immediate hospitalization for patients with warning signs, including intravenous fluid resuscitation and intensive monitoring 2, 4

The critical phase typically occurs around days 4-6 when plasma leakage and severe complications develop, according to the World Health Organization, and patients should be monitored closely during this period 2, 4
The Centers for Disease Control and Prevention recommend baseline platelet count and hematocrit, as well as daily monitoring during days 3-7 for outpatients, and more frequent monitoring for hospitalized patients 2
Rising hematocrit (>20% increase) indicates plasma leakage and impending severe dengue, as suggested by the World Health Organization 2

Patient education on danger signs is crucial, and patients should be instructed to return immediately for severe abdominal pain, persistent vomiting, bleeding, altered mental status, cold extremities, or decreased urine output, as recommended by the Centers for Disease Control and Prevention 2, 4
The World Health Organization suggests scheduling follow-up within 24-48 hours or providing clear instructions for daily self-monitoring with immediate return if warning signs develop 2, 4